glp 1 and bariatric surgery Metabolic vs. GLP-1 Receptor Agonists for Obesity Management Glucagon-Like Peptide-1 Receptor Agonists in

[DOI] [PMC free article] [PubMed] [Google Scholar] 79.Marla S.S., Lee J., Groves J.T

For Systemic (Abdominal): Choose a spot on the abdomen, at least one inch from the navel

ZnPPIX, an inhibitor of HO-1, can diminish the antioxidant effect of honokiol

Discovering the link between nutrition and skin aging

over 40% of the excess clusters in the first 3 months

As mechanistic insights into iron homeostasis, lipid peroxidation, and immunometabolic interactions continue to deepen, alongside progress in drug delivery, gene editing, and regenerative medicine, therapies targeting ferroptosis may represent a promising new paradigm in OA management, ultimately enhancing joint function and overall quality of life for affected individuals